Inve US ▾
BABAX

Baxter International (BAX) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Jul 30, 2026

Source: earnings call transcript

Baxter delivered strong Q2 FY26 results, driven by broad-based organic growth and a significant tariff refund, exceeding expectations. The company is making steady progress on its turnaround strategy, focusing on business stabilization, balance sheet strengthening, and continuous improvement through Baxter GPS, while actively managing supply chain challenges and the Novum IQ LVP hold. Management expressed confidence in achieving full-year targets and reducing net leverage.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.